Clean Cells was founded in July 2000 by three biomedical research scientists from INSERM (the French National Institute for Health and Medical Research):

• Olivier BOISTEAU (cellular pharmacology)

• Frédéric HENRY (cancer immunotherapy)

• Marc MEICHENIN (cancer immunotherapy)
  

 

 

Their previous experience had given them expertise in cell culture procedures, molecular biology, bacteriology and in-vivo manipulation and a knowledge of biopharmaceutical product regulation which they were able to draw on when setting up Clean Cells.

Between the three of them, they have a majority shareholding in the company, which now employs about 30 people. Other companies such as Pays de la Loire Développement, have also invested capital to support its development.

The recipient of awards from the ‘Aventis - Institut de France’ foundation for its innovations and from the ‘Réseau Entreprendre Atlantique’ association since its creation, Clean Cells develops high value-added services for all its clients, responding to their demand for new services to take account of changing needs arising from technological, scientific or regulatory developments.

Since its creation, Clean Cells has been part of the Western France Biocluster ‘Atlanpole Biotherapies’, an enterprise centre supported by the French government; Olivier BOISTEAU was appointed President of Atlantople Biotherapies in December 2008.